Flaunting The Feminine Side Of Research Studies

摘要

Trials and Tribulations, 10 October, p. 219). Recently, a 2008 review of National Heart, Lung, and Blood Institute (NHLBI)-funded cardiovascular disease (CVD) randomized controlled clinical trials from 1997 to 2006 found that women were underrepresented based on general population incidence as reported by the American Heart Association's Heart Disease and Stroke Statistics report. "The mean percent of women enrolled in all trials was 27% versus 53% of all patients with CVD who are women" (2).